Fatty liver disease happens when fat builds up in liver cells beyond what the organ can process and export. It affects more than 30% of the global population, making it one of the most common liver conditions worldwide. The causes fall into two broad categories: alcohol-related and metabolic, though genetics, diet, medications, and even rapid weight loss can all play a role.
The Two Main Types of Fatty Liver
Doctors now use the term metabolic dysfunction-associated steatotic liver disease (MASLD) for what was previously called nonalcoholic fatty liver disease (NAFLD). This type is tied to metabolic problems like obesity, insulin resistance, and high blood sugar. The other type, alcohol-associated liver disease, results from heavy drinking over time. Both follow a similar path of damage: fat accumulation, then inflammation, then scarring, and potentially cirrhosis or liver cancer.
Although the progression looks similar under a microscope, there are differences. In the metabolic type, fat buildup in liver cells tends to be more extensive. In the alcohol-related type, inflammatory cell activity is more pronounced. In practice, the two can overlap. A newer category called MetALD describes people who have metabolic fatty liver and also drink moderately to heavily.
Insulin Resistance and Metabolic Causes
The most common driver of fatty liver is insulin resistance, the condition where your body’s cells stop responding efficiently to insulin. When fat tissue becomes insulin resistant, it releases stored fat into the bloodstream at a higher rate than normal. These free fatty acids travel to the liver through the bloodstream, and the liver absorbs them faster than it can burn or export them. The excess gets stored as fat droplets inside liver cells.
This is why fatty liver is so tightly linked to type 2 diabetes and obesity. Roughly 67% of people with diabetes and 65% of people with obesity have concurrent fatty liver disease. The condition is essentially a liver manifestation of the same metabolic dysfunction that drives high blood sugar and weight gain. Insulin resistance also triggers the liver to ramp up its own fat production, compounding the problem.
How Diet Contributes
Not all sugars affect the liver equally. Fructose is a significantly more potent trigger of liver fat production than glucose. The reason comes down to how the liver processes it: the enzyme that handles fructose works about 10 times faster than the one that handles glucose, and it operates without a feedback mechanism to slow it down. This means fructose floods into liver metabolism unchecked, and much of it gets converted directly into fat.
A randomized controlled trial gave 94 healthy men drinks sweetened with glucose, fructose, or sucrose (about 80 grams of sugar daily) for six weeks. Fructose and sucrose drinks increased the liver’s baseline fat-producing activity compared to controls, while pure glucose drinks did not. In a separate study, beverages containing fructose stimulated liver fat production more potently than beverages containing only glucose, even when total sugar calories were identical. This helps explain why sugary sodas, fruit juices, and processed foods sweetened with high-fructose corn syrup are so consistently linked to fatty liver.
High-fat, low-fiber diets also contribute by disrupting the balance of gut bacteria, increasing intestinal permeability, and allowing inflammatory molecules to reach the liver through the portal vein.
Alcohol’s Role
Alcohol is a direct liver toxin when consumed in excess. The threshold for liver damage is lower than many people assume, and it differs by sex. For men, the risk rises sharply at 40 to 60 grams of alcohol per day, which translates to roughly 3 to 5 standard drinks. For women, the threshold is about 20 grams per day, less than 2 drinks. A standard drink is 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of liquor, each containing about 12 grams of alcohol.
A large Danish study tracking over 13,000 people for 12 years found a steep, dose-dependent increase in liver disease risk above 14 to 27 drinks per week in men and 7 to 13 drinks per week in women. Both the amount and the duration of drinking matter. Women face higher risk of progression to cirrhosis than men at the same relative intake levels.
Genetics and the PNPLA3 Gene
Some people develop fatty liver without being overweight, diabetic, or heavy drinkers. Genetics are often the explanation. In 2008, a genome-wide study identified a variant in the PNPLA3 gene (known as I148M) that is strongly associated with fatty liver independent of body weight, diabetes, or alcohol use. People who carry this variant have a version of the PNPLA3 protein that is less effective at breaking down fat stored in liver cells and also harder for the body to clear away through its normal recycling processes. The result is that fat-laden droplets accumulate in liver tissue more easily.
This gene variant is more common in certain ethnic groups, which partly explains why fatty liver rates vary across populations even after accounting for diet and lifestyle.
The Gut-Liver Connection
Your gut and liver are directly connected by the portal vein, which carries blood from the intestines to the liver. When the gut’s protective lining breaks down, a condition called increased intestinal permeability, bacterial toxins leak through and travel straight to the liver. The most important of these is a molecule found on the surface of certain bacteria that triggers a strong inflammatory response in liver tissue.
People with fatty liver have significantly more of these bacteria, particularly certain types that produce this toxin, compared to healthy individuals. Once these toxins reach the liver, they activate immune signaling that releases inflammatory molecules, which in turn accelerate fat accumulation and scarring. This creates a feedback loop: a high-fat, low-fiber diet disrupts gut bacteria, weakens the intestinal barrier, sends inflammatory signals to the liver, and worsens the very fat buildup that was already there. It also increases circulating free fatty acids and triggers insulin resistance, further compounding the metabolic problem.
Medications That Cause Fatty Liver
Several widely used medications can cause fat to accumulate in the liver as a side effect. The most well-documented include corticosteroids (often prescribed for inflammation and autoimmune conditions), methotrexate (used for rheumatoid arthritis and certain cancers), tamoxifen (used in breast cancer treatment), the heart rhythm drug amiodarone, and the seizure medication valproic acid. Total parenteral nutrition, where all calories are delivered intravenously, can also cause fatty liver.
Tamoxifen-related fatty liver is the most commonly encountered drug-induced form. Methotrexate can cause progressive liver damage that begins with fatty changes and can advance to scarring and cirrhosis with long-term use. If you take any of these medications, your doctor likely monitors your liver function periodically for this reason.
Why Rapid Weight Loss Can Backfire
Losing weight gradually is one of the most effective treatments for fatty liver, but losing it too quickly can paradoxically make things worse. When someone who is significantly overweight drops weight rapidly through extreme calorie restriction, crash dieting, or bariatric surgery, fat stored in visceral tissue gets mobilized faster than the liver can handle. Free fatty acids flood the portal circulation and overwhelm liver cells.
As the liver tries to process this sudden influx, it generates reactive oxygen species that damage cell structures and trigger inflammation. At the same time, malnutrition depletes the liver’s antioxidant reserves, leaving it less capable of handling the oxidative stress. Increased intestinal permeability from malnutrition adds another layer of insult by allowing bacterial toxins into the portal blood. A liver that is already fatty is less tolerant of oxidative stress than a healthy liver, which means the damage can escalate quickly. This is why gradual weight loss of 1 to 2 pounds per week is generally recommended over aggressive approaches.